Study to compare cycle control and safety of the oral contraceptive SH T 00186 D (0.02 mg Ethinylestradiol and 3 mg Drospirenone) in a 21-day regimen vs. Mercilon®
Please see attached Study Results Summary below.
No Inclusion Criteria Available
No Exclusion Criteria Available
Multi-center, open, randomized, parallel group comparison of cycle control and safety of the oral contraceptive SH T 00186 D (Ethinylestradiol-ß-Cyclodextrin Clathrate (equivalent to 0.02 mg ethinylestradiol) and 3 mg drospirenone) in a 21-day regimen vs. Mercilon® for 7 cycles in 400 healthy female volunteers